• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用染色质构型的计算分析将阿尔茨海默病变体映射到其靶基因

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration.

作者信息

Matoba Nana, Quiroga Ivana Y, Phanstiel Douglas H, Won Hyejung

机构信息

Department of Genetics, University of North Carolina; Neuroscience Center, University of North Carolina.

Thurston Arthritis Research Center, University of North Carolina.

出版信息

J Vis Exp. 2020 Jan 9(155). doi: 10.3791/60428.

DOI:10.3791/60428
PMID:31984958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11659877/
Abstract

Genome-wide association studies (GWAS) have successfully identified hundreds of genomic loci that are associated with human traits and disease. However, because the majority of the genome-wide significant (GWS) loci fall onto the non-coding genome, the functional impact of many remain unknown. Three-dimensional chromatin interactions identified by Hi-C or its derivatives can provide useful tools to annotate these loci by linking non-coding variants to their actionable genes. Here, we outline a protocol to map GWAS non-coding variants to their putative genes using Alzheimer's disease (AD) GWAS and Hi-C datasets from human adult brain tissue. Putative causal single-nucleotide polymorphisms (SNPs) are identified by application of fine-mapping algorithms. SNPs are then mapped to their putative target genes using enhancer-promoter interactions based on Hi-C. The resulting gene set represents AD risk genes, as they are potentially regulated by AD risk variants. To garner further biological insights into molecular mechanisms underlying AD, we characterize AD risk genes using developmental brain expression data and brain single-cell expression profiles. This protocol can be expanded to any GWAS and Hi-C datasets to identify putative target genes and molecular mechanisms underlying various human traits and diseases.

摘要

全基因组关联研究(GWAS)已成功鉴定出数百个与人类性状和疾病相关的基因组位点。然而,由于大多数全基因组显著(GWS)位点位于非编码基因组上,许多位点的功能影响仍不明确。通过Hi-C或其衍生技术鉴定的三维染色质相互作用可以提供有用的工具,通过将非编码变异与其可作用的基因联系起来注释这些位点。在这里,我们概述了一种使用来自人类成人大脑组织的阿尔茨海默病(AD)GWAS和Hi-C数据集,将GWAS非编码变异映射到其推定基因的方案。通过应用精细定位算法鉴定推定的因果单核苷酸多态性(SNP)。然后基于Hi-C,利用增强子-启动子相互作用将SNP映射到其推定的靶基因。所得的基因集代表AD风险基因,因为它们可能受AD风险变异的调控。为了进一步深入了解AD潜在的分子机制,我们利用发育中的大脑表达数据和大脑单细胞表达谱对AD风险基因进行表征。该方案可以扩展到任何GWAS和Hi-C数据集,以鉴定各种人类性状和疾病潜在的靶基因和分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ef/11659877/62d7a25eb910/nihms-2036731-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ef/11659877/39b76856776a/nihms-2036731-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ef/11659877/62d7a25eb910/nihms-2036731-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ef/11659877/39b76856776a/nihms-2036731-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93ef/11659877/62d7a25eb910/nihms-2036731-f0002.jpg

相似文献

1
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration.利用染色质构型的计算分析将阿尔茨海默病变体映射到其靶基因
J Vis Exp. 2020 Jan 9(155). doi: 10.3791/60428.
2
Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.与阿尔茨海默病相关的增强子变异通过染色质环影响基因表达。
BMC Med Genomics. 2019 Sep 9;12(1):128. doi: 10.1186/s12920-019-0574-8.
3
Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.推断非编码阿尔茨海默病相关遗传变异的分子机制。
J Alzheimers Dis. 2019;72(1):301-318. doi: 10.3233/JAD-190568.
4
Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia.基于大脑和血液组织参考转录组数据的贝叶斯全基因组 TWAS 鉴定出 141 个阿尔茨海默病痴呆风险基因。
Alzheimers Res Ther. 2024 Jun 1;16(1):120. doi: 10.1186/s13195-024-01488-7.
5
Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.与冠心病风险相关的肝脏特异性非编码调控 SNPs 的综合分析。
Am J Hum Genet. 2021 Mar 4;108(3):411-430. doi: 10.1016/j.ajhg.2021.02.006. Epub 2021 Feb 23.
6
The complex genetic architecture of Alzheimer's disease: novel insights and future directions.阿尔茨海默病的复杂遗传结构:新的见解和未来方向。
EBioMedicine. 2023 Apr;90:104511. doi: 10.1016/j.ebiom.2023.104511. Epub 2023 Mar 10.
7
Structural variants linked to Alzheimer's disease and other common age-related clinical and neuropathologic traits.与阿尔茨海默病及其他常见的年龄相关临床和神经病理学特征相关的结构变异
Genome Med. 2025 Mar 4;17(1):20. doi: 10.1186/s13073-025-01444-6.
8
Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.基于全基因组关联研究、微阵列和 RNA-seq 数据鉴定阿尔茨海默病病理中的关键长非编码 RNA 及其功能。
J Alzheimers Dis. 2019;68(1):339-355. doi: 10.3233/JAD-181051.
9
Alzheimer's Disease Variants with the Genome-Wide Significance are Significantly Enriched in Immune Pathways and Active in Immune Cells.具有全基因组意义的阿尔茨海默病变体在免疫通路中显著富集,并在免疫细胞中活跃。
Mol Neurobiol. 2017 Jan;54(1):594-600. doi: 10.1007/s12035-015-9670-8. Epub 2016 Jan 9.
10
Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk.超越关联:将非编码遗传变异与调节阿尔茨海默病风险的功能后果联系起来的成功和挑战。
Mol Neurodegener. 2021 Apr 21;16(1):27. doi: 10.1186/s13024-021-00449-0.

引用本文的文献

1
Advances in profiling chromatin architecture shed light on the regulatory dynamics underlying brain disorders.解析染色质结构的研究进展揭示了大脑疾病相关调控动态的本质。
Semin Cell Dev Biol. 2022 Jan;121:153-160. doi: 10.1016/j.semcdb.2021.08.013. Epub 2021 Sep 3.
2
Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.神经元和神经胶质的 3D 染色质结构为脑部疾病的细胞病因学提供了线索。
Nat Commun. 2021 Jun 25;12(1):3968. doi: 10.1038/s41467-021-24243-0.

本文引用的文献

1
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.精神障碍的八大类疾病中的基因组关系、新位点和多效机制。
Cell. 2019 Dec 12;179(7):1469-1482.e11. doi: 10.1016/j.cell.2019.11.020.
2
The three-dimensional landscape of the genome in human brain tissue unveils regulatory mechanisms leading to schizophrenia risk.人类脑组织中基因组的三维景观揭示了导致精神分裂症风险的调控机制。
Schizophr Res. 2020 Mar;217:17-25. doi: 10.1016/j.schres.2019.03.007. Epub 2019 Mar 18.
3
Identification of common genetic risk variants for autism spectrum disorder.
孤独症谱系障碍常见遗传风险变异的鉴定。
Nat Genet. 2019 Mar;51(3):431-444. doi: 10.1038/s41588-019-0344-8. Epub 2019 Feb 25.
4
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.全基因组荟萃分析确定了新的位点和功能途径,影响阿尔茨海默病的风险。
Nat Genet. 2019 Mar;51(3):404-413. doi: 10.1038/s41588-018-0311-9. Epub 2019 Jan 7.
5
Comprehensive functional genomic resource and integrative model for the human brain.人类大脑的综合功能基因组资源和整合模型。
Science. 2018 Dec 14;362(6420). doi: 10.1126/science.aat8464.
6
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.发现首个与注意缺陷多动障碍全基因组显著相关的风险位点。
Nat Genet. 2019 Jan;51(1):63-75. doi: 10.1038/s41588-018-0269-7. Epub 2018 Nov 26.
7
Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.进行性核上性麻痹的全基因组关联研究确定了新的易感性位点,并与神经退行性疾病存在遗传相关性。
Mol Neurodegener. 2018 Aug 8;13(1):41. doi: 10.1186/s13024-018-0270-8.
8
Amyloid β oligomers (AβOs) in Alzheimer's disease.阿尔茨海默病中的淀粉样β寡聚物(AβOs)。
J Neural Transm (Vienna). 2018 Feb;125(2):177-191. doi: 10.1007/s00702-017-1820-x. Epub 2017 Dec 1.
9
Microglia in Alzheimer's disease.阿尔茨海默病中的小胶质细胞。
J Cell Biol. 2018 Feb 5;217(2):459-472. doi: 10.1083/jcb.201709069. Epub 2017 Dec 1.
10
Chromosome conformation elucidates regulatory relationships in developing human brain.染色体构象揭示了发育中的人类大脑中的调控关系。
Nature. 2016 Oct 27;538(7626):523-527. doi: 10.1038/nature19847. Epub 2016 Oct 19.